Satellite Banner
Technology Networks Header
Wednesday, October 01, 2014
 
Register | Sign in
Home Page>Products
  Product News
Rigaku to Showcase Customizable Handheld Raman Analyzer for RMID
Saturday, August 16, 2014
Company will showcase Progeny in booth 1C82 at CPhI Worldwide 2014.

The Hiden HMT Vacuum Process Diagnostic
Saturday, August 16, 2014
Monitoring by Faraday detector at high pressure and at lower pressures by electron multiplier detector.

BioTek’s New Synergy™ HTX Multi-Mode Microplate Reader
Saturday, August 16, 2014
Offers convenient, flexible and automated microplate-based detection.

Reproducible Evaporation of Environmental Samples
Thursday, August 14, 2014
EZ-2 ENVI from Genevac give excellent recovery and reproducibility.

BioTek’s Gen5 Software Offers CVB Relative Potency Solution
Thursday, August 14, 2014
Company will describe the use of Gen5 software at webinar on September 25, 2014.

Rigaku Concludes Successful 3rd European SmartLab Workshop in Karlsruhe
Thursday, August 14, 2014
Workshop focused on application and operation of the SmartLab Intelligent X-ray diffraction system.

Bioo Scientific First to Address Small RNA-Seq Bias Concerns
Wednesday, August 13, 2014
Company launches NEXTflex™ Small RNA Sequencing Kit v2.

Protagen AG Launches Landmark First Research Test Kit for Systemic Sclerosis
Wednesday, August 13, 2014
The new assay was developed to synergistically combine two proprietary, novel disease markers with two standard diagnostic markers to support medical research in autoimmune diseases.

HORIBA Scientific Releases LabSpec 6.3 Software Update
Tuesday, August 12, 2014
Enhanced capabilities include full 3D volume display for Raman spectroscopy.

<< 10 11 12 13 14 15 16 >>
Showing Results 121 - 130 of 10525
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv